Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a fixed-dose ophthalmic combination of three active ingredients: - **Dexamethasone** (a synthetic corticosteroid): Reduces ocular inflammation by suppressing the immune response and decreasing the production of inflammatory mediators. - **Pranoprofen** (a non-steroidal anti-inflammatory drug, NSAID): Inhibits cyclooxygenase enzymes, reducing prostaglandin synthesis and thereby decreasing pain and inflammation in the eye. - **Tobramycin** (an aminoglycoside antibiotic): Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, providing broad-spectrum antibacterial activity against common ocular pathogens. This combination is used as an eye drop for treating or preventing inflammation and infection after ocular surgery or in conditions such as endophthalmitis. Clinical studies indicate that this triple therapy can more effectively reduce inflammation, improve visual recovery, and lower adverse reaction rates compared to dual combinations or other regimens[1][2]. Each component addresses a different aspect of post-surgical or infectious complications—dexamethasone for potent anti-inflammation, pranoprofen for additional anti-inflammatory/analgesic effect via a different pathway, and tobramycin for antimicrobial coverage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dexamethasone + pranoprofen + tobramycin.